BIOMAT Database Logo BIOMAT Database Logo

Identification of Btk mutations in 20 unrelated patients with X-linked agammaglobulinaemia (XLA). 1995

H Jin, and A D Webster, and M Vihinen, and P Sideras, and I Vorechovsky, and L Hammarstróm, and E Bernatowska-Matuszkiewicz, and C I Smith, and M Bobrow, and D Vetrie
Division of Medical and Molecular Genetics, UMDS of Guy's Hospital, London, UK.

X-linked agammaglobulinaemia (XLA) is an inherited immunodeficiency resulting from mutations in the gene for a cytoplasmic protein tyrosine kinase (Btk). We have utilised reverse-transcription-based PCR in combination with the chemical cleavage and mismatch technique (CCM) to screen for Btk mutations in 42 unrelated patients having classical XLA or 'leaky' XLA-like phenotypes. A variety of mutations, including point mutations, large deletions and splicing defects were detected using this strategy. In total, 20 mutations were found in these patients. All the mutations were different with the exception of three unrelated patients who all showed the same Arg-->His amino acid substitution (R641H) at a highly-conserved residue in the kinase domain. We have also used structural modelling of the Btk kinase domain to predict how two different amino acid substitution mutations at highly-conserved residues are likely to affect the Btk kinase activity.

UI MeSH Term Description Entries
D008040 Genetic Linkage The co-inheritance of two or more non-allelic GENES due to their being located more or less closely on the same CHROMOSOME. Genetic Linkage Analysis,Linkage, Genetic,Analyses, Genetic Linkage,Analysis, Genetic Linkage,Genetic Linkage Analyses,Linkage Analyses, Genetic,Linkage Analysis, Genetic
D008297 Male Males
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D011505 Protein-Tyrosine Kinases Protein kinases that catalyze the PHOSPHORYLATION of TYROSINE residues in proteins with ATP or other nucleotides as phosphate donors. Tyrosine Protein Kinase,Tyrosine-Specific Protein Kinase,Protein-Tyrosine Kinase,Tyrosine Kinase,Tyrosine Protein Kinases,Tyrosine-Specific Protein Kinases,Tyrosylprotein Kinase,Kinase, Protein-Tyrosine,Kinase, Tyrosine,Kinase, Tyrosine Protein,Kinase, Tyrosine-Specific Protein,Kinase, Tyrosylprotein,Kinases, Protein-Tyrosine,Kinases, Tyrosine Protein,Kinases, Tyrosine-Specific Protein,Protein Kinase, Tyrosine-Specific,Protein Kinases, Tyrosine,Protein Kinases, Tyrosine-Specific,Protein Tyrosine Kinase,Protein Tyrosine Kinases,Tyrosine Specific Protein Kinase,Tyrosine Specific Protein Kinases
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077329 Agammaglobulinaemia Tyrosine Kinase A non-receptor tyrosine kinase that is essential for the development, maturation, and signaling of B-LYMPHOCYTES. It contains an N-terminal zinc finger motif and localizes primarily to the PLASMA MEMBRANE and nucleus of B-lymphocytes. Mutations in the gene that encode this kinase are associated with X-LINKED AGAMMAGLOBULINEMIA. B Cell Progenitor Kinase,Bruton's Tyrosine Kinase,Bruton Tyrosine Kinase,Brutons Tyrosine Kinase,Kinase, Agammaglobulinaemia Tyrosine,Kinase, Bruton's Tyrosine,Tyrosine Kinase, Agammaglobulinaemia,Tyrosine Kinase, Bruton's
D000361 Agammaglobulinemia An immunologic deficiency state characterized by an extremely low level of generally all classes of gamma-globulin in the blood. Hypogammaglobulinemia,Agammaglobulinemias,Hypogammaglobulinemias
D000596 Amino Acids Organic compounds that generally contain an amino (-NH2) and a carboxyl (-COOH) group. Twenty alpha-amino acids are the subunits which are polymerized to form proteins. Amino Acid,Acid, Amino,Acids, Amino
D001483 Base Sequence The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence. DNA Sequence,Nucleotide Sequence,RNA Sequence,DNA Sequences,Base Sequences,Nucleotide Sequences,RNA Sequences,Sequence, Base,Sequence, DNA,Sequence, Nucleotide,Sequence, RNA,Sequences, Base,Sequences, DNA,Sequences, Nucleotide,Sequences, RNA

Related Publications

H Jin, and A D Webster, and M Vihinen, and P Sideras, and I Vorechovsky, and L Hammarstróm, and E Bernatowska-Matuszkiewicz, and C I Smith, and M Bobrow, and D Vetrie
Identification of the bruton tyrosine kinase (BTK) gene mutations in 20 Australian families with X-linked agammaglobulinemia (XLA).
April 2004, Human mutation,
H Jin, and A D Webster, and M Vihinen, and P Sideras, and I Vorechovsky, and L Hammarstróm, and E Bernatowska-Matuszkiewicz, and C I Smith, and M Bobrow, and D Vetrie
Analysis of Btk mutations in patients with X-linked agammaglobulinaemia (XLA) and determination of carrier status in normal female relatives: a nationwide study of Btk deficiency in Greece.
September 2001, Scandinavian journal of immunology,
H Jin, and A D Webster, and M Vihinen, and P Sideras, and I Vorechovsky, and L Hammarstróm, and E Bernatowska-Matuszkiewicz, and C I Smith, and M Bobrow, and D Vetrie
Identification of novel Bruton's tyrosine kinase mutations in 10 unrelated subjects with X linked agammaglobulinaemia.
June 1997, Journal of medical genetics,
H Jin, and A D Webster, and M Vihinen, and P Sideras, and I Vorechovsky, and L Hammarstróm, and E Bernatowska-Matuszkiewicz, and C I Smith, and M Bobrow, and D Vetrie
X-linked agammaglobulinaemia (XLA) presenting with neutropenia and Pseudomonas aeruginosa cellulitis.
December 2016, Archives of disease in childhood,
H Jin, and A D Webster, and M Vihinen, and P Sideras, and I Vorechovsky, and L Hammarstróm, and E Bernatowska-Matuszkiewicz, and C I Smith, and M Bobrow, and D Vetrie
Bruton tyrosine kinase (BTK) in X-linked agammaglobulinemia (XLA).
December 2000, Frontiers in bioscience : a journal and virtual library,
H Jin, and A D Webster, and M Vihinen, and P Sideras, and I Vorechovsky, and L Hammarstróm, and E Bernatowska-Matuszkiewicz, and C I Smith, and M Bobrow, and D Vetrie
X-linked agammaglobulinemia (XLA): a genetic tyrosine kinase (Btk) disease.
October 1996, BioEssays : news and reviews in molecular, cellular and developmental biology,
H Jin, and A D Webster, and M Vihinen, and P Sideras, and I Vorechovsky, and L Hammarstróm, and E Bernatowska-Matuszkiewicz, and C I Smith, and M Bobrow, and D Vetrie
Kinase mutant Btk results in atypical X-linked agammaglobulinaemia phenotype.
May 2000, Clinical and experimental immunology,
H Jin, and A D Webster, and M Vihinen, and P Sideras, and I Vorechovsky, and L Hammarstróm, and E Bernatowska-Matuszkiewicz, and C I Smith, and M Bobrow, and D Vetrie
Mutations of the Btk gene in 12 unrelated families with X-linked agammaglobulinemia in Japan.
April 1996, Human genetics,
H Jin, and A D Webster, and M Vihinen, and P Sideras, and I Vorechovsky, and L Hammarstróm, and E Bernatowska-Matuszkiewicz, and C I Smith, and M Bobrow, and D Vetrie
Mutations in btk in patients with presumed X-linked agammaglobulinemia.
May 1998, American journal of human genetics,
H Jin, and A D Webster, and M Vihinen, and P Sideras, and I Vorechovsky, and L Hammarstróm, and E Bernatowska-Matuszkiewicz, and C I Smith, and M Bobrow, and D Vetrie
Structural basis for X-linked agammaglobulinemia (XLA): mutations at interacting Btk residues R562, W563, and A582.
September 1995, Clinical immunology and immunopathology,
Copied contents to your clipboard!